Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Buy
71
LRCX Quote, Financials, Valuation and Earnings
Last price:
$222.91
Seasonality move
:
8.5%
Day range:
$215.93 - $225.35
52-week range:
$56.32 - $236.10
Dividend yield:
0.44%
P/E ratio:
49.11x
P/S ratio:
14.58x
P/B ratio:
27.46x
Volume:
10.1M
Avg. volume:
12.3M
1-year change:
179.71%
Market cap:
$279.9B
Revenue:
$18.4B
EPS (TTM):
$4.54
Analysts' Opinion
-
Consensus RatingLam Research Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 22 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $215.35, Lam Research Corp. has an estimated downside of -3.37% from its current price of $222.87.
-
Price Target UpsideAccording to analysts, the highest upside price target is $265.00 representing 18.9% upside increase from its current price of $222.87.
Fair Value
-
According to the consensus of 32 analysts, Lam Research Corp. has -3.37% downside to fair value with a price target of $215.35 per share.
LRCX vs. S&P 500
-
Over the past 5 trading days, Lam Research Corp. has overperformed the S&P 500 by 0.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Lam Research Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lam Research Corp. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Lam Research Corp. reported revenues of $5.3B.
Earnings Growth
-
Lam Research Corp. has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Lam Research Corp. reported earnings per share of $1.24.
Enterprise value:
277.7B
EV / Invested capital:
--
Price / LTM sales:
14.58x
EV / EBIT:
42.95x
EV / Revenue:
14.18x
PEG ratio (5yr expected):
1.05x
EV / Free cash flow:
50.04x
Price / Operating cash flow:
51.46x
Enterprise value / EBITDA:
40.49x
Gross Profit (TTM):
$9.7B
Return On Assets:
28.32%
Net Income Margin (TTM):
29.66%
Return On Equity:
62.02%
Return On Invested Capital:
41.19%
Operating Margin:
34.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15.8B | $15.6B | $19.6B | $4.2B | $5.3B | |
| Gross Profit | $7.2B | $7.4B | $9.7B | $2B | $2.7B | |
| Operating Income | $4.6B | $4.6B | $6.5B | $1.3B | $1.8B | |
| EBITDA | $5B | $4.9B | $6.9B | $1.4B | $1.9B | |
| Diluted EPS | $2.94 | $3.09 | $4.54 | $0.86 | $1.24 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.1B | $13.6B | $13B | $13.5B | $14.8B | |
| Total Assets | $15.6B | $18.7B | $18.5B | $19.5B | $21.9B | |
| Current Liabilities | $3.4B | $5.1B | $4.2B | $5.3B | $6.7B | |
| Total Liabilities | $9.7B | $11.3B | $10.5B | $11.1B | $11.7B | |
| Total Equity | $5.8B | $7.4B | $8B | $8.5B | $10.2B | |
| Total Debt | $5B | $5B | $5B | $5B | $4.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.9B | $5.3B | $6.4B | $1.6B | $1.8B | |
| Cash From Investing | -$481.4M | -$406.5M | -$783.6M | -$110.6M | -$186M | |
| Cash From Financing | -$3.8B | -$3.9B | -$5B | -$1.3B | -$1.3B | |
| Free Cash Flow | $4.5B | $4.8B | $5.6B | $1.5B | $1.6B | |
LRCX
Sector
Market Cap
$279.9B
$50.1M
Price % of 52-Week High
94.4%
58.3%
Dividend Yield
0.44%
0%
Shareholder Yield
2.74%
--
1-Year Price Total Return
179.71%
-15.66%
Beta (5-Year)
1.774
0.647
Dividend yield:
0.44%
Annualized payout:
$0.92
Payout ratio:
21.04%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$220.19
200-day SMA
Buy
Level
$123.30
Bollinger Bands (100)
Buy
Level
127.09 - 187.71
Chaikin Money Flow
Buy
Level
3.4M
20-day SMA
Buy
Level
$205.22
Relative Strength Index (RSI14)
Buy
Level
66.25
ADX Line
Sell
Level
9.96
Williams %R
Neutral
Level
-32.2211
50-day SMA
Buy
Level
$177.29
MACD (12, 26)
Buy
Level
31.20
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Sell
Level
-18.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (10.5768)
Buy
CA Score
(Annual)
Level (1.0349)
Buy
Beneish M-Score
(Annual)
Level (-2.3468)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.6514)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.
Stock Forecast FAQ
In the current month, LRCX has received 22 Buy ratings 10 Hold ratings, and 0 Sell ratings. The LRCX average analyst price target in the past 3 months is $215.35.
-
Where Will Lam Research Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lam Research Corp. share price will drop to $215.35 per share over the next 12 months.
-
What Do Analysts Say About Lam Research Corp.?
Analysts are divided on their view about Lam Research Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lam Research Corp. is a Sell and believe this share price will rise from its current level to $115.00.
-
What Is Lam Research Corp.'s Price Target?
The price target for Lam Research Corp. over the next 1-year time period is forecast to be $215.35 according to 32 Wall Street analysts, 22 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is LRCX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lam Research Corp. is a Buy. 22 of 32 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LRCX?
You can purchase shares of Lam Research Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lam Research Corp. shares.
-
What Is The Lam Research Corp. Share Price Today?
Lam Research Corp. was last trading at $222.91 per share. This represents the most recent stock quote for Lam Research Corp.. Yesterday, Lam Research Corp. closed at $222.87 per share.
-
How To Buy Lam Research Corp. Stock Online?
In order to purchase Lam Research Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get LRCX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LRCX
Sector
P/E ratio
49.11x
24.38x
PEG ratio
1.05x
0.00x
P/B ratio
27.46x
2.20x
Price / LTM sales
14.58x
1.43x
Growth Metrics
LRCX
Sector
Revenue growth
27.74%
6.61%
Earnings growth
44.35%
11.02%
Revenue (5-year growth)
12.92%
4.78%
Earnings forecast
$1.17
$0.14
Profitability
LRCX
Sector
Profitability FY 2025
$9B
$28.6M
Return on invested capital
41.19%
-0.79%
Return on assets
28.32%
-1.56%
Return on equity
62.02%
0.15%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Jan
28
Estimated Next Earnings Date
Jan
21
Balance Sheet
LRCX
Sector
Total cash
$6.7B
$37.7M
Short term investments
--
$16.1M
Total assets
$21.3B
$150.4M
Long term debt
$4.5B
$4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is up 279.19% over the past day.
Buy
71
GLSI alert for Jan 27
Greenwich LifeSciences, Inc. [GLSI] is up 19.36% over the past day.
Sell
48
RVMD alert for Jan 27
Revolution Medicines, Inc. [RVMD] is down 16.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
